CIGLIANO, Antonio

CIGLIANO, Antonio  

MEDICINA, CHIRURGIA E FARMACIA  

Mostra records
Risultati 1 - 20 di 60 (tempo di esecuzione: 0.092 secondi).
Titolo Data di pubblicazione Autore(i) File
A proteomic approach to differentiate histologically classified stable and unstable plaques from human carotid arteries. IF 2009: 4.522 JCR: Q1 1-gen-2009 Lepedda, Antonio Junior; Cigliano, A; Cherchi, Gm; Spirito, R; Maggioni, M; Carta, F; Turrini, F; Edelstein, C; Scanu, Am; Formato, Marilena
Aortic and pulmonary bioprosthetic heart valves: an insight on glycosaminoglycan distribution and fine structure in decellularized porcine scaffolds for tissue engineering purposes 24-feb-2009 Cigliano, Antonio
Association between human plasma chondroitin sulphate isomers and carotid atherosclerotic plaque 1-gen-2012 Zinellu, E; Lepedda, Antonio Junior; Cigliano, A; Pisanu, S; Zinellu, Angelo; Carru, Ciriaco; Bacciu, Pp; Piredda, F; Guarino, A; Spirito, R; Formato, Marilena
Both de novo synthetized and exogenous fatty acids support the growth of hepatocellular carcinoma cells 1-gen-2017 Cao, Dan; Song, Xinhua; Che, Li; Li, Xiaolei; Pilo, Maria G.; Vidili, Gianpaolo; Porcu, Alberto; Solinas, Antonio; Cigliano, Antonio; Pes, Giovanni M.; Ribback, Silvia; Dombrowski, Frank; Chen, Xin; Li, Lei; Calvisi, Diego F.
Cabozantinib-based combination therapy for the treatment of hepatocellular carcinoma 1-gen-2020 Shang, R.; Song, X.; Wang, P.; Zhou, Y.; Lu, X.; Wang, J.; Xu, M.; Chen, X.; Utpatel, K.; Che, L.; Liang, B.; Cigliano, A.; Evert, M.; Calvisi, D. F.; Chen, X.
CD90 is regulated by notch1 and hallmarks a more aggressive intrahepatic cholangiocarcinoma phenotype 1-gen-2022 Mancarella, S.; Serino, G.; Gigante, I.; Cigliano, A.; Ribback, S.; Sanese, P.; Grossi, V.; Simone, C.; Armentano, R.; Evert, M.; Calvisi, D. F.; Giannelli, G.
Central role of mTORC1 downstream of YAP/TAZ in hepatoblastoma development 1-gen-2017 Liu, P.; Calvisi, D. F.; Kiss, A.; Cigliano, A.; Schaff, Z.; Che, L.; Ribback, S.; Dombrowski, F.; Zhao, D.; Chen, X.
Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans 1-gen-2019 Che, Li; Chi, Wenna; Qiao, Yu; Zhang, Jie; Song, Xinhua; Liu, Ye; Li, Lei; Jia, Jiaoyuan; Pilo, Maria G.; Wang, Jingxiao; Cigliano, Antonio; Ma, Zhilong; Kuang, Wenhua; Tang, Zefang; Zhang, Zemin; Shui, Guanghou; Ribback, Silvia; Dombrowski, Frank; Evert, Matthias; Pascale, Rosa Maria; Cossu, Carla; Pes, Giovanni Mario; Osborne, Timothy F.; Calvisi, Diego F.; Chen, Xin; Chen, Ligong
Co-activation of AKT and c-Met triggers rapid hepatocellular carcinoma development via the mTORC1/FASN pathway in mice 1-gen-2016 Hu, Junjie; Che, Li; Li, Lei; Pilo, Maria Giulia; Cigliano, Antonio; Ribback, Silvia; Li, Xiaolei; Latte, Gavinella; Mela, Marta; Evert, Matthias; Dombrowski, Frank; Zheng, Guohua; Chen, Xin; Calvisi, Diego Francesco
Combined CDK4/6 and pan-mTOR inhibition is synergistic against intrahepatic cholangiocarcinoma 1-gen-2019 Song, X.; Liu, X.; Wang, H.; Wang, J.; Qiao, Y.; Cigliano, A.; Utpatel, K.; Ribback, S.; Pilo, M. G.; Serra, M.; Gordan, J. D.; Che, L.; Zhang, S.; Cossu, A.; Porcu, A.; Pascale, R. M.; Dombrowski, F.; Hu, H.; Calvisi, D. F.; Evert, M.; Chen, X.
Corrigendum to ‘TAZ is indispensable for c-MYC-induced hepatocarcinogenesis’ [J Hepatol (2022) 123–134] (Journal of Hepatology (2022) 76(1) (123–134), (S016882782102016X), (10.1016/j.jhep.2021.08.021)) 1-gen-2022 Wang, H.; Zhang, S.; Zhang, Y.; Jia, J.; Wang, J.; Liu, X.; Zhang, J.; Song, X.; Ribback, S.; Cigliano, A.; Evert, M.; Liang, B.; Wu, H.; Calvisi, D. F.; Zeng, Y.; Chen, X.
Crenigacestat, a selective NOTCH1 inhibitor, reduces intrahepatic cholangiocarcinoma progression by blocking VEGFA/DLL4/MMP13 axis 1-gen-2020 Mancarella, S.; Serino, G.; Dituri, F.; Cigliano, A.; Ribback, S.; Wang, J.; Chen, X.; Calvisi, D. F.; Giannelli, G.
Current challenges to underpinning the genetic basis for cholangiocarcinoma 1-gen-2021 Cigliano, A.; Chen, X.; Calvisi, D. F.
Deregulated c-Myc requires a functional HSF1 for experimental and human hepatocarcinogenesis 1-gen-2017 Cigliano, Antonio; Pilo, Maria G.; Li, Lei; Latte, Gavinella; Szydlowska, Marta; Simile, Maria M.; Paliogiannis, Panagiotis; Che, Li; Pes, Giovanni M.; Palmieri, Giuseppe; Sini, Maria C.; Cossu, Antonio; Porcu, Alberto; Vidili, Gianpaolo; Seddaiu, Maria A.; Pascale, Rosa M.; Ribback, Silvia; Dombrowski, Frank; Chen, Xin; Calvisi, Diego F.
Differential requirement for de novo lipogenesis in cholangiocarcinoma and hepatocellular carcinoma of mice and humans 1-gen-2016 Li, Lei; Che, Li; Tharp, Kevin M.; Park, Hyo Min; Pilo, Maria Giulia; Cao, Dan; Cigliano, Antonio; Latte, Gavinella; Xu, Zhong; Ribback, Silvia; Dombrowski, Frank; Evert, Matthias; Gores, Gregory J.; Stahl, Andreas; Calvisi, Diego Francesco; Chen, Xin
Distinct and Overlapping Roles of Hippo Effectors YAP and TAZ During Human and Mouse Hepatocarcinogenesis. 1-gen-2021 Wang, Haichuan; Wang, Jingxiao; Zhang, Shanshan; Jia, Jiaoyuan; Liu, Xianqiong; Zhang, Jie; Wang, Pan; Song, Xinhua; Che, Li; Liu, Ke; Ribback, Silvia; Cigliano, Antonio; Evert, Matthias; Wu, Hong; F Calvisi, Diego; Zeng, Yong; Chen, Xin
Efficacy of MEK inhibition in a K-Ras-driven cholangiocarcinoma preclinical model 1-gen-2018 Dong, M.; Liu, X.; Evert, K.; Utpatel, K.; Peters, M.; Zhang, S.; Xu, Z.; Che, L.; Cigliano, A.; Ribback, S.; Dombrowski, F.; Cossu, A.; Gordan, J.; Calvisi, D. F.; Evert, M.; Liu, Y.; Chen, X.
The Epidermal Growth Factor Receptor (EGFR) Inhibitor Gefitinib Reduces but Does Not Prevent Tumorigenesis in Chemical and Hormonal Induced Hepatocarcinogenesis Rat Models 1-gen-2016 Ribback, Silvia; Sailer, Verena; Böhning, Enrico; Günther, Julia; Merz, Jaqueline; Steinmüller, Frauke; Utpatel, Kirsten; Cigliano, Antonio; Peters, Kristin; Pilo, Maria Giulia; Evert, Matthias; Calvisi, Diego Francesco; Dombrowski, Frank
Erratum: Frizzled-10 extracellular vesicles plasma concentration is associated with tumoral progression in patients with colorectal and gastric cancer (Journal of Oncology (2019) 2019 (2715968) DOI: 10.1155/2019/2715968) 1-gen-2020 Scavo, M. P.; Cigliano, A.; Depalo, N.; Fanizza, E.; Bianco, M. G.; Denora, N.; Laquintana, V.; Curri, M. L.; Lorusso, D.; Lotesoriere, C.; Panarese, A.; Giannelli, G.
Focal adhesion kinase activation limits efficacy of Dasatinib in c-Myc driven hepatocellular carcinoma 1-gen-2018 Liu, X.; Song, X.; Zhang, J.; Xu, Z.; Che, L.; Qiao, Y.; Ortiz Pedraza, Y.; Cigliano, A.; Pascale, R. M.; Calvisi, D. F.; Liu, Y.; Chen, X.